Welcome to our dedicated page for MOBIX LABS SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mobix Labs, Inc. filings document the public-company disclosures of a fabless semiconductor and connectivity company serving defense, aerospace, telecommunications and other high-reliability markets. Registration statements and prospectus materials cover Class A common stock offerings, resale registration matters and financial disclosures tied to its capital needs.
Material-event reports cover securities purchase agreements, a senior secured convertible promissory note, registration rights, the completed reverse stock split of Class A and Class B common stock, and related adjustments to equity plans and outstanding securities. Proxy and annual meeting filings describe director elections, stockholder voting matters, bylaw amendments, quorum requirements and other governance provisions.
Mobix Labs, Inc. filed Amendment No. 1 to its annual report for the year ended September 30, 2025 to add detailed Part III information on directors, executive officers, compensation, security ownership, related-party transactions and auditor fees that was previously expected to come from the proxy statement.
The filing describes a classified, mostly independent board, recent leadership changes including Philip Sansone becoming CEO, and sizeable equity awards and severance protections for co-founders and senior executives. It also outlines substantial RSU and option grants to non-employee directors, significant beneficial ownership stakes held by insiders and Armistice Capital, related-party financing and PIPE arrangements, broad indemnification protections, and PwC audit fees of $1,556,000 in 2025.
Mobix Labs, Inc. filed its annual report for the year ended September 30, 2025, detailing a small specialized player in advanced wireless and wired connectivity, RF, and EMI filtering for defense, aerospace, industrial and medical markets. The company expanded through its acquisitions of EMI Solutions in December 2023 and RaGE Systems in May 2024, broadening its interconnect and wireless systems portfolio.
Mobix reported operating losses of $37.7 million in 2025 and $46.4 million in 2024, with an accumulated deficit of $150.6 million as of September 30, 2025, and disclosed substantial doubt about its ability to continue as a going concern without new capital. As of March 31, 2025, the non‑affiliate market value of its common stock was about $30.5 million. The company relies heavily on a few customers, with Leidos Holdings representing roughly 50% of 2025 net revenue.
Mobix had 46 employees as of September 30, 2025 and 64,308,034 Class A and 2,004,901 Class B shares outstanding as of November 30, 2025. It operates in highly competitive semiconductor and interconnect markets, highlights a strategy centered on mmWave IC development and further acquisitions, and lists extensive risk factors including customer concentration, need for additional financing, material weaknesses in internal controls, and Nasdaq listing compliance risk.
Mobix Labs, Inc. insider Samini Keyvan reported equity award activity and a related share sale. On December 21, 2025, 333,333 Restricted Stock Units vested and converted into 333,333 shares of Class A Common Stock at a stated price of $0.00 per share. On January 5, 2026, Keyvan sold 211,672 shares of Class A Common Stock at a weighted average price of $0.3243 per share, with prices ranging from $0.32 to $0.328 per share. According to the disclosure, these shares were sold solely to satisfy tax withholding obligations from the RSU vesting under a pre-arranged sell-to-cover election and are not discretionary trades. Following these transactions, Keyvan directly beneficially owns 2,671,661 shares of Class A Common Stock, with additional indirect holdings through family trusts, and holds fully vested options covering 323,529 Class A shares.
Mobix Labs, Inc. is conducting a primary offering of up to 30,000,000 shares of Class A common stock at $0.20 per share, for gross proceeds of about $6.0 million. After placement fees and expenses, Mobix estimates net proceeds of approximately $5.135 million, which it plans to use for working capital and general corporate purposes.
The deal is a best-efforts offering through D. Boral Capital, with no minimum amount and no escrow; funds become immediately available to the company even if the maximum is not sold. Existing holders face immediate and substantial dilution, as the share count would rise from 64,308,034 to 94,308,034 Class A shares if the full amount is issued, and additional dilution could come from options, RSUs, warrants and earnout shares.
The company highlights going concern risks and the need for additional capital, and it is currently not in compliance with Nasdaq’s minimum bid price and market value listing standards, with an extension to regain compliance by April 27, 2026. Failure to comply could lead to delisting, which may reduce liquidity and make future financing more difficult.
Mobix Labs, Inc. entered into securities purchase agreements for a public offering of 30,000,000 shares of its Class A common stock at $0.20 per share.
The company engaged D. Boral Capital LLC as placement agent, agreeing to an 8.0% cash placement fee, up to 1.0% of gross proceeds for non-accountable expenses, and up to $100,000 for legal and other expenses. Net proceeds to Mobix Labs were approximately $5,135,000, which the company plans to use for working capital and other general corporate purposes. The company agreed to short-term restrictions on additional equity issuances and variable rate transactions, and its executive officers and directors entered 30-day lock-up agreements on their holdings following the closing.
Mobix Labs has a Form 144 notice indicating a planned sale of up to 211,672 shares of its Class A common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $68,654.56 and 58,620,000 shares outstanding.
The shares relate to 333,333 common shares acquired on 12/21/2025 through vesting of restricted stock units from Mobix Labs, with the transaction described as an RSU vest paid on that date.
Mobix Labs, Inc. (MOBX) reported an insider transaction by its Chief Executive Officer and director. On 11/21/2025, the reporting person sold 100,044 shares of Class A common stock at a weighted average price of $0.412 per share. The filing explains that these shares were sold to cover withholding tax obligations tied to the vesting of restricted stock units.
After this transaction, the reporting person beneficially owns 1,935,841 shares of Class A common stock, held directly. The sale prices ranged from $0.4001 to $0.4151 per share, and detailed pricing information is available upon request from the reporting person.
Mobix Labs, Inc. (MOBX) reported an insider transaction by its Chief Technology Officer on a Form 4. On 11/21/2025, the CTO sold 22,470 shares of Class A common stock at a weighted average price of $0.4069 per share. The filing explains that these shares were sold to cover withholding tax obligations related to the vesting of restricted stock units.
After this transaction, the CTO beneficially owns 106,523 shares of Class A common stock. The filing also lists fully vested stock options giving the right to buy 16,112 shares and 183 shares of Class A common stock at an exercise price of $6.84 per share, with an expiration date of 04/04/2032.
Mobix Labs, Inc. filed Prospectus Supplement No. 5 covering up to 15,373,309 shares of Class A common stock. The supplement incorporates a recent update: the company amended certain outstanding warrants covering 13,375,490 shares so they are classified as equity rather than liabilities, and issued an additional warrant for 1,000,000 shares with a $1.08 exercise price. The company states no cash consideration was exchanged for these amendments.
Mobix also reported two debt-for-equity exchanges: 227,954 shares issued for $204,931.07 of obligations and 687,894 shares for $510,791.67 of indebtedness. Nasdaq granted an extension to regain the $1.00 minimum bid price through April 27, 2026. The company notes prior warrant liabilities of approximately $6.3 million are now reflected within stockholders’ equity. Mobix’s Class A common stock closed at $0.6929 on October 30, 2025.
Mobix Labs (MOBX) amended warrants covering 13,375,490 shares to qualify for equity classification under applicable accounting guidance, removing them from liability treatment on its balance sheet. As part of the amendments, the company issued an additional warrant for 1,000,000 shares at an exercise price of $1.08, with no cash consideration exchanged.
The company also completed two debt-for-equity exchanges, issuing 227,954 shares to settle $204,931.07 owed to Acromax and 687,894 shares to settle $510,791.67 owed to Alessandra. The warrant amendments relate to instruments previously classified as liabilities of approximately $6.3 million, which are now reflected in stockholders’ equity.
Separately, Nasdaq granted MOBX an extension through April 27, 2026 to regain compliance with the $1.00 minimum bid-price rule. The stock previously met the $1.00 threshold for ten consecutive days, and Nasdaq required maintaining it for twenty consecutive business days. Management states stockholders’ equity now exceeds $5 million and believes the company meets other qualitative and quantitative listing standards.